130 related articles for article (PubMed ID: 29702282)
1. Wedelolactone inhibits osteoclastogenesis but enhances osteoblastogenesis through altering different semaphorins production.
Deng X; Liang LN; Zhu D; Zheng LP; Yu JH; Meng XL; Zhao YN; Sun XX; Pan TW; Liu YQ
Int Immunopharmacol; 2018 Jul; 60():41-49. PubMed ID: 29702282
[TBL] [Abstract][Full Text] [Related]
2. Wedelolactone enhances osteoblastogenesis by regulating Wnt/β-catenin signaling pathway but suppresses osteoclastogenesis by NF-κB/c-fos/NFATc1 pathway.
Liu YQ; Hong ZL; Zhan LB; Chu HY; Zhang XZ; Li GH
Sci Rep; 2016 Aug; 6():32260. PubMed ID: 27558652
[TBL] [Abstract][Full Text] [Related]
3. Wedelolactone Enhances Osteoblastogenesis but Inhibits Osteoclastogenesis through Sema3A/NRP1/PlexinA1 Pathway.
Liu YQ; Han XF; Bo JX; Ma HP
Front Pharmacol; 2016; 7():375. PubMed ID: 27803667
[TBL] [Abstract][Full Text] [Related]
4. Inhibitory effect of Ecliptae herba extract and its component wedelolactone on pre-osteoclastic proliferation and differentiation.
Liu YQ; Zhan LB; Liu T; Cheng MC; Liu XY; Xiao HB
J Ethnopharmacol; 2014 Nov; 157():206-11. PubMed ID: 25267578
[TBL] [Abstract][Full Text] [Related]
5. Adenosine A
Mediero A; Wilder T; Shah L; Cronstein BN
FASEB J; 2018 Jul; 32(7):3487-3501. PubMed ID: 29394106
[TBL] [Abstract][Full Text] [Related]
6. Wedelolactone Enhances Osteoblastogenesis through ERK- and JNK-mediated BMP2 Expression and Smad/1/5/8 Phosphorylation.
Zhu D; Deng X; Han XF; Sun XX; Pan TW; Zheng LP; Liu YQ
Molecules; 2018 Mar; 23(3):. PubMed ID: 29498687
[TBL] [Abstract][Full Text] [Related]
7. Effect of hydroxyapatite nanoparticles and wedelolactone on osteoblastogenesis from bone marrow mesenchymal stem cells.
Dong P; Zhu D; Deng X; Zhang Y; Ma J; Sun X; Liu Y
J Biomed Mater Res A; 2019 Jan; 107(1):145-153. PubMed ID: 30289597
[TBL] [Abstract][Full Text] [Related]
8. Role of inhibition of osteogenesis function by Sema4D/Plexin-B1 signaling pathway in skeletal fluorosis in vitro.
Liu XL; Song J; Liu KJ; Wang WP; Xu C; Zhang YZ; Liu Y
J Huazhong Univ Sci Technolog Med Sci; 2015 Oct; 35(5):712-715. PubMed ID: 26489627
[TBL] [Abstract][Full Text] [Related]
9. DOK3 Modulates Bone Remodeling by Negatively Regulating Osteoclastogenesis and Positively Regulating Osteoblastogenesis.
Cai X; Xing J; Long CL; Peng Q; Humphrey MB
J Bone Miner Res; 2017 Nov; 32(11):2207-2218. PubMed ID: 28650106
[TBL] [Abstract][Full Text] [Related]
10. The combined effect of oleonuezhenide and wedelolactone on proliferation and osteoblastogenesis of bone marrow mesenchymal stem cells.
Deng X; Tan S; Zhu D; Sun Y; Yu J; Meng X; Zheng L; Liu Y
Phytomedicine; 2019 Dec; 65():153103. PubMed ID: 31805425
[TBL] [Abstract][Full Text] [Related]
11. Chinese Ecliptae herba (Eclipta prostrata (L.) L.) extract and its component wedelolactone enhances osteoblastogenesis of bone marrow mesenchymal stem cells via targeting METTL3-mediated m6A RNA methylation.
Tian S; Li YL; Wang J; Dong RC; Wei J; Ma Y; Liu YQ
J Ethnopharmacol; 2023 Aug; 312():116433. PubMed ID: 37004744
[TBL] [Abstract][Full Text] [Related]
12. Icariin influences adipogenic differentiation of stem cells affected by osteoblast-osteoclast co-culture and clinical research adipogenic.
Zhang S; Feng P; Mo G; Li D; Li Y; Mo L; Yang Z; Liang D
Biomed Pharmacother; 2017 Apr; 88():436-442. PubMed ID: 28122309
[TBL] [Abstract][Full Text] [Related]
13. Dual-Function Semaphorin 4D Released by Platelets: Suppression of Osteoblastogenesis and Promotion of Osteoclastogenesis.
Shindo S; Savitri IJ; Ishii T; Ikeda A; Pierrelus R; Heidari A; Okubo K; Nakamura S; Kandalam U; Rawas-Qalaji M; Leon E; Pastore MR; Hardigan P; Kawai T
Int J Mol Sci; 2022 Mar; 23(6):. PubMed ID: 35328359
[TBL] [Abstract][Full Text] [Related]
14. Osteoblastogenesis and osteoprotection enhanced by flavonolignan silibinin in osteoblasts and osteoclasts.
Kim JL; Kang SW; Kang MK; Gong JH; Lee ES; Han SJ; Kang YH
J Cell Biochem; 2012 Jan; 113(1):247-59. PubMed ID: 21898547
[TBL] [Abstract][Full Text] [Related]
15. Pioglitazone affects the OPG/RANKL/RANK system and increase osteoclastogenesis.
Xu F; Dong Y; Huang X; Chen P; Guo F; Chen A; Huang S
Mol Med Rep; 2016 Sep; 14(3):2289-96. PubMed ID: 27430581
[TBL] [Abstract][Full Text] [Related]
16. Influence of sinomenine upon mesenchymal stem cells in osteoclastogenesis.
Zhou B; Lu X; Tang Z; Liu D; Zhou Y; Zeng P; Xiong H
Biomed Pharmacother; 2017 Jun; 90():835-841. PubMed ID: 28437887
[TBL] [Abstract][Full Text] [Related]
17. Biological effects of melatonin on osteoblast/osteoclast cocultures, bone, and quality of life: Implications of a role for MT2 melatonin receptors, MEK1/2, and MEK5 in melatonin-mediated osteoblastogenesis.
Maria S; Samsonraj RM; Munmun F; Glas J; Silvestros M; Kotlarczyk MP; Rylands R; Dudakovic A; van Wijnen AJ; Enderby LT; Lassila H; Dodda B; Davis VL; Balk J; Burow M; Bunnell BA; Witt-Enderby PA
J Pineal Res; 2018 Apr; 64(3):. PubMed ID: 29285799
[TBL] [Abstract][Full Text] [Related]
18. Treatment of OPG-deficient mice with WP9QY, a RANKL-binding peptide, recovers alveolar bone loss by suppressing osteoclastogenesis and enhancing osteoblastogenesis.
Ozaki Y; Koide M; Furuya Y; Ninomiya T; Yasuda H; Nakamura M; Kobayashi Y; Takahashi N; Yoshinari N; Udagawa N
PLoS One; 2017; 12(9):e0184904. PubMed ID: 28937990
[TBL] [Abstract][Full Text] [Related]
19. The Simultaneous Inhibitory Effect of Niclosamide on RANKL-Induced Osteoclast Formation and Osteoblast Differentiation.
Liu FL; Chen CL; Lee CC; Wu CC; Hsu TH; Tsai CY; Huang HS; Chang DM
Int J Med Sci; 2017; 14(9):840-852. PubMed ID: 28824321
[TBL] [Abstract][Full Text] [Related]
20. Dominant negative N-cadherin inhibits osteoclast differentiation by interfering with beta-catenin regulation of RANKL, independent of cell-cell adhesion.
Shin CS; Her SJ; Kim JA; Kim DH; Kim SW; Kim SY; Kim HS; Park KH; Kim JG; Kitazawa R; Cheng SL; Civitelli R
J Bone Miner Res; 2005 Dec; 20(12):2200-12. PubMed ID: 16294273
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
